Print Print page     Email Email page

Press Releases

All Releases
View Summary VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
Jun 11, 2009
PDF 10.6 KB Add to Briefcase
View Summary VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation
Jun 4, 2009
PDF 10.5 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients
May 14, 2009
PDF 11.8 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
May 1, 2009
PDF 11.5 KB Add to Briefcase
View Summary VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
Apr 3, 2009
PDF 9.8 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
Mar 31, 2009
PDF 10.3 KB Add to Briefcase
View Summary VIA Pharmaceuticals Complies With NASDAQ Rules
Mar 27, 2009
PDF 9.9 KB Add to Briefcase
View Summary VIA Pharmaceuticals Secures Financing Up to $10.0 Million
Mar 12, 2009
PDF 10.3 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291
Feb 25, 2009
PDF 9.6 KB Add to Briefcase
View Summary VIA Pharmaceuticals Licenses Drug Candidates from Roche to Expand Cardiovascular Pipeline to Include Metabolic Disease
Dec 23, 2008
PDF 10.7 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
Nov 9, 2008
PDF 17.2 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
Nov 6, 2008
PDF 7.1 KB Add to Briefcase
View Summary VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations
Nov 4, 2008
PDF 6.7 KB Add to Briefcase
View Summary VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
Sep 24, 2008
PDF 10.3 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
Sep 15, 2008
PDF 9.9 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
Sep 9, 2008
PDF 10.8 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit 2008
Sep 9, 2008
PDF 7.2 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
Aug 12, 2008
PDF 7.2 KB Add to Briefcase
View Summary VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
Aug 1, 2008
PDF 6.8 KB Add to Briefcase
View Summary VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
Jul 10, 2008
PDF 11.3 KB Add to Briefcase
Showing 1-20 of 59 Page: 1 2 3  Next 20
= add release to Briefcase